Research Topics
Genomes and GenesSpecies | W W FleischhackerSummaryAffiliation: University of Innsbruck Country: Austria Publications
| Collaborators
|
Detail Information
Publications
Comparative efficacy of antipsychotics in the treatment of schizophrenia: a critical assessmentRajiv Tandon
Office of Mental Health, Department of Children and Families, State of Florida, 1317 Winewood Boulevard, Tallahassee, FL 32399 0700, USA
Schizophr Res 79:145-55. 2005..Dosing appears to be a critical variable in optimizing efficacy...
The first-episode of schizophrenia: a challenge for treatmentW W Fleischhacker
Department of Biological Psychiatry, Innsbruck University Clinics, Anichstrasse 35, A 6020 Innsbruck, Austria
Eur Psychiatry 17:371s-375s. 2002..The main challenge in this phase of the illness is therefore to convince patients that maintenance treatment is necessary in order to assure the best possible outcome...
Treatment of schizophrenia patients: comparing new-generation antipsychotics to each otherW Wolfgang Fleischhacker
Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
Curr Opin Psychiatry 19:128-34. 2006....
Placebo or active control trials of antipsychotic drugs?W Wolfgang Fleischhacker
Department of Biological Psychiatry, Innsbruck University Clinics, Austria
Arch Gen Psychiatry 60:458-64. 2003..Sample size requirements for various equivalence margins in noninferiority trials are provided. Scientific and ethical arguments should lead to a more frequent use of the active-control noninferiority trial design...
[Pharmacotherapy for schizophrenia]W W Fleischhacker
Abteilung für Biologische Psychiatrie, Medizinische Universitat Innsbruck, Anichstrasse 35, 6020 Innsbruck, Osterreich
Nervenarzt 77:S77-97; S98. 2006..This review is meant to serve as a guide for clinicians involved in managing schizophrenia, whether in a psychiatric hospital setting or as family physicians in private practice...
Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychoticW Wolfgang Fleischhacker
Department of Biological Psychiatry, Innsbruck University Clinics, Anichstrasse 35, 6020 Innsbruck, Austria
J Clin Psychiatry 64:1250-7. 2003..The long-term safety and efficacy of long-acting injectable risperidone, the first long-acting second-generation antipsychotic, were evaluated in stable patients with schizophrenia...
Feasibility of placebo-controlled clinical trials of antipsychotic compounds in EuropeW Wolfgang Fleischhacker
Department of Biological Psychiatry, Innsbruck University Clinics, Anichstrasse 35, 6020 Innsbruck, Austria
Psychopharmacology (Berl) 162:82-4. 2002..Most recent phase II and phase III PCTs of antipsychotics in schizophrenia have been conducted outside Europe. This development needs to be better understood...
Factors influencing compliance in schizophrenia patientsW Wolfgang Fleischhacker
Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, Austria
J Clin Psychiatry 64:10-3. 2003....
The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trialW Wolfgang Fleischhacker
Department of Biological Psychiatry, Medical University Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
Schizophr Res 78:147-56. 2005..These and other facts have stimulated discussions regarding the effectiveness of the new generation of antipsychotics...
Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 yearW Wolfgang Fleischhacker
Department of Biological Psychiatry, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
Br J Psychiatry 187:131-6. 2005..The extent to which antipsychotics improve patients' well-being is uncertain...
[Extrapyramidal side-effects: avoidance, diagnosis and treatment]W Wolfgang Fleischhacker
Abteilung für Biologische Psychiatrie Universitätsklinik für Psychiatrie Innsbruck, Medizinische Universitat Innsbruck
Psychiatr Prax 32:S25-30. 2005..Nevertheless, there are some conflicting results on this topic. This article discusses some of these results and sheds light on methodological problems in the evaluation of side-effects of antipsychotic treatment...
[Problems in evaluating new antipsychotic drugs]W W Fleischhacker
Abteilung für Biologische Psychiatrie, Universitätsklinik für Psychiatrie, Innsbruck
Wien Med Wochenschr 148:266-72. 1998..Clinical psychiatrists also face the challenge to modify some of the traditional treatment approaches. These prerequisites will allow the embedding of novel antipsychotics into modern integrative treatment concepts of schizophrenia...
Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomesW W Fleischhacker
Innsbruck University Clinics, Department of Biological Psychiatry, Austria
Drugs 53:915-29. 1997..Long term maintenance therapy is crucial and continuous monitoring for the development of adverse effects essential...
Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophreniaA Hofer
Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
Acta Psychiatr Scand 116:354-61. 2007....
Sexual disturbances during clozapine and haloperidol treatment for schizophreniaM Hummer
Department of Biological Psychiatry, Innsbruck University Clinics, Austria
Am J Psychiatry 156:631-3. 1999..The aim of this study was to evaluate the frequency and course of sexual disturbances associated with clozapine and haloperidol and their potential influence on compliance with medication regimens in patients with schizophrenia...
Quality of life measurement in oncology--a matter of the assessment instrument?B Holzner
Department of Biological Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A 6020 Innsbruck, Austria
Eur J Cancer 37:2349-56. 2001..The results of the QoL investigations should not be interpreted independently of the instrument used and an interpretation of results must be based on the contents of items of the respective questionnaires...
Symptomatic remission and neurocognitive functioning in patients with schizophreniaA Hofer
Medical University Innsbruck, Department of Psychiatry and Psychotherapy, Biological Psychiatry Division, Innsbruck, Austria
Psychol Med 41:2131-9. 2011....
Clozapine: a comparison with other novel antipsychoticsW W Fleischhacker
Department of Biological Psychiatry, Innsbruck University Clinics, Austria
J Clin Psychiatry 60:30-4. 1999....
Effects of six second generation antipsychotics on body weight and metabolism - risk assessment and results from a prospective studyA Tschoner
Department of Internal Medicine I, Medical University Innsbruck, Innsbruck, Austria
Pharmacopsychiatry 42:29-34. 2009..Due to the association of second generation antipsychotics (SGAs) with weight gain and alterations of glucose and lipid homeostasis, we aimed to group six commonly prescribed SGAs into classes of differing risks...
Outcomes in schizophrenia outpatients treated with amisulpride or olanzapineA Hofer
Department of Biological Psychiatry, Innsbruck Medical University, Austria
Pharmacopsychiatry 40:1-8. 2007..We compared stable patients with schizophrenia who were treated with either amisulpride or olanzapine in terms of symptomatic outcome, neurocognitive functioning, functionality, and subjective outcome...
Neutropenia induced by second generation antipsychotics: a prospective investigationM A Rettenbacher
Medical University Innsbruck, Department of Psychiatry, Innsbruck, Austria
Pharmacopsychiatry 43:41-4. 2010..We prospectively investigated schizophrenia patients treated with second generation antipsychotics with respect to alterations of white blood cell counts...
Association of olanzapine-induced weight gain with an increase in body fatU Eder
Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, Austria
Am J Psychiatry 158:1719-22. 2001..The goal of this study was to explore the pathophysiology of weight gain during treatment with olanzapine for schizophrenia...
Brain activation pattern during a verbal fluency test in healthy male and female volunteers: a functional magnetic resonance imaging studyE M Weiss
Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, Austria
Neurosci Lett 352:191-4. 2003..Our data argue against genuine between-sex differences in cerebral activation patterns during lexical verbal fluency activities when confounding factors like performance differences are excluded...
Selection bias in clinical trials with antipsychoticsA Hofer
Department of Biological Psychiatry, University Clinics Innsbruck, Austria
J Clin Psychopharmacol 20:699-702. 2000..A history of noncompliance with previous treatment and the refusal of consent were the most common reasons for not including theoretically eligible patients in a clinical trial...
Metabolic side effects of antipsychotic medicationA Tschoner
Clinical Division of General Internal Medicine, Department of Internal Medicine, Medical University Innsbruck, Anichstrasse, Innsbruck, Austria
Int J Clin Pract 61:1356-70. 2007..However, further trials are required to support a specific therapeutical approach as well as studies to investigate the underlying mechanisms for future drug development...
The clinical implications of weight gain in schizophreniaI Kurzthaler
Department of Biological Psychiatry, Innsbruck University Clinics, Austria
J Clin Psychiatry 62:32-7. 2001..Physicians must be aware of the problem of weight gain associated with schizophrenia and choose antipsychotic medication carefully, especially in patients at high risk for weight gain...
Cognitive impairment in schizophrenia: clinical ratings are not a suitable alternative to neuropsychological testingAlex Hofer
Medical University Innsbruck, Department of Biological Psychiatry, Anichstrasse 35, A 6020 Innsbruck, Austria
Schizophr Res 92:126-31. 2007..These data clearly show that clinical assessment of cognitive deficits by the PANSS is not a viable alternative to neuropsychological testing to obtain information about cognitive functioning in schizophrenia...
A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophreniaW Wolfgang Fleischhacker
Department of Biological Psychiatry, Medical University of Innsbruck, Austria
Biol Psychiatry 65:510-7. 2009..Few studies have directly compared the efficacy and tolerability of atypical agents...
Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional studyPeter Malik
Department of Biological Psychiatry, Medical University Innsbruck, Anichstrasse 35, Innsbruck, Austria
Alcohol Clin Exp Res 33:375-81. 2009..Ethanol's direct effect on bone-modeling cells as well as alcoholism-related "life-style factors" such as malnutrition, lack of exercise, hormonal changes, and liver cirrhosis are discussed as potential causative factors...
Quality of life in breast cancer patients--not enough attention for long-term survivors?B Holzner
Department of Biological Psychiatry, Innsbruck University Hospital, Austria
Psychosomatics 42:117-23. 2001..The findings imply that besides recovering from the acute consequences of cancer therapy, long-term survivors of breast cancer (> 5 years after initial treatment) still may have a special need for psycho-oncological support...
Risk factors for the development of neuroleptic induced akathisiaC H Miller
Department of Biological Psychiatry, Innsbruck University Clinics, Austria
Eur Neuropsychopharmacol 7:51-5. 1997..75% of all NIA cases occurred within the first three days of antipsychotic treatment. When attempting to determine risk factors for the development of NIA, we found a significant influence of dose increase in the first days of treatment...
Factors influencing the choice of new generation antipsychotic medication in the treatment of patients with schizophreniaMonika Edlinger
University Clinic of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University Innsbruck, Innsbruck, Austria
Schizophr Res 113:246-51. 2009..This prospective, naturalistic study investigated the factors influencing physicians' choice of antipsychotic drug therapy in the treatment of patients with schizophrenia...
A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone databaseW W Fleischhacker
Dept of Biological Psychiatry, Innsbruck University Clinics, Austria
Pharmacopsychiatry 34:104-10. 2001..To provide more definitive answers, EPS assessments in future studies should be refined to more accurately predict the type of EPS expected with a given agent in clinical practice...
Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessmentM Kopp
Department of Psychiatry, University Hospital Innsbruck, Austria
Ann Hematol 77:27-32. 1998..Patients should be informed about potential deficits in physical and emotional well-being within the first year after BMT. This could enhance insight and compliance in the critical period early after BMT...
Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatmentJ Marksteiner
Department of Psychiatry, University of Innsbruck, A 6020, Innsbruck, Austria
Neuroscience 104:325-33. 2001..From these results we suggest that phencyclidine may induce synaptic alterations in specific brain areas and may contribute to a better understanding of synaptic dysfunction which may also occur in schizophrenia...
EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparisonM Kopp
Department of General Psychiatry, Innsbruck University Hospital, Austria
Eur J Haematol 65:97-103. 2000..We therefore conclude that neither of the two instruments can be replaced by the other in the assessment of QOL of BMT patients and that a direct comparison of results obtained with the two instruments is likely to be misleading...
Intravenous versus oral administration of amitriptyline in patients with major depressionE A Deisenhammer
Department of General Psychiatry, University of Innsbruck, Austria
J Clin Psychopharmacol 20:417-22. 2000..The results of this study do not clearly favor one of the tested options. The main differences found in this study seem to be dose-related rather than differentiating between oral and intravenous routes of administration...
Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effectsAlex Hofer
Department of Biological Psychiatry, Innsbruck Medical University, Anichstrasse 35, A 6020 Innsbruck, Austria
Eur Psychiatry 20:386-94. 2005..The present cross-sectional study examined the relationships of psychopathology, side effects, and sociodemographic factors with treatment outcomes in terms of patients' quality of life (QOL), functioning, and needs for care...
Alcohol and benzodiazepines in falls: an epidemiological viewIlsemarie Kurzthaler
Department of Biological Psychiatry, Medical University Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
Drug Alcohol Depend 79:225-30. 2005..5%; females=2.4%). In addition, this study shows that alcohol plays a more important role in patients up to 70 years in fall-related accidents when compared to accidents of other causes...
Various bilateral olfactory deficits in male patients with schizophreniaClaudia I Rupp
Department of General Psychiatry, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria
Schizophr Bull 31:155-65. 2005..Olfactory dysfunctions were found across both nostrils. Results suggest specific dysfunctions in olfactory processing in schizophrenia patients, including early stages of the odor identification process...
QTc variability in schizophrenia patients treated with antipsychotics and healthy controlsMaria A Rettenbacher
Department of Biological Psychiatry, Innsbruck University Hospital, A 6020 Innsbruck, Austria
J Clin Psychopharmacol 25:206-10. 2005....
The effect of nabilone on neuropsychological functions related to driving ability: an extended case seriesIlsemarie Kurzthaler
Department of Biological Psychiatry, Innsbruck University Clinics, Austria
Hum Psychopharmacol 20:291-3. 2005..No indication was found of a deterioration of any of the five investigated neuropsychological functions during the 4-week treatment period with nabilone...
Patient outcomes in schizophrenia II: the impact of cognitionAlex Hofer
Department of Biological Psychiatry, Innsbruck Medical University, Anichstrasse 35, A 6020 Innsbruck, Austria
Eur Psychiatry 20:395-402. 2005..Associations have been found between the severity of cognitive deficits and social dysfunction, impairments in independent living, occupational limitations, and disturbances in quality of life (QOL)...
Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorderAlex Hofer
Department of Biological Psychiatry, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
Eur Arch Psychiatry Clin Neurosci 256:246-55. 2006..Our observations suggest that subjective and functional outcomes in highly compliant patients are mainly predicted by psychopathological symptoms and unchangeable sociodemographic variables...
Alcohol and/or benzodiazepine use: different accidents--different impacts?Ilsemarie Kurzthaler
Department of Biological Psychiatry, Medical University Innsbruck, Austria
Hum Psychopharmacol 20:583-9. 2005..This study adds evidence to the existing literature about the co-occurance of alcohol and/or benzodiazepine consumption and accident-related injuries...
Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysisGeorg Kemmler
Department of General Psychiatry, Innsbruck University Clinics, Anichstrasse 35, A 6020 Innsbruck, Austria
Arch Gen Psychiatry 62:1305-12. 2005..Dropout rates in randomized clinical trials of antipsychotic drugs have consistently been reported to be high, and the use of a placebo-controlled design is hypothesized to be one of the reasons for this...
Language lateralization in unmedicated patients during an acute episode of schizophrenia: a functional MRI studyElisabeth M Weiss
Department of General Psychiatry, Anichstrasse 35, Innsbruck Medical University, A 6020 Innsbruck, Austria
Psychiatry Res 146:185-90. 2006..These results suggest that decreased language lateralization is also evident in unmedicated patients experiencing an acute episode of schizophrenia...
Attitudes of patients with schizophrenia and depression towards psychiatric researchMonika Edlinger
Medical University Innsbruck, Department of Psychiatry and Psychotherapy, University Clinic of Biological Psychiatry, Anichstrasse 35, A 6020 Innsbruck, Austria
Psychiatry Res 177:172-6. 2010..Our findings confirm and extend those of other groups. This should encourage psychiatrists at least in academic settings where most of this research has been done to approach patients to take part in clinical research...
Neural substrates for episodic encoding and recognition of unfamiliar facesAlex Hofer
Medical University Innsbruck, Department of Biological Psychiatry, Anichstrasse 35, A 6020 Innsbruck, Austria
Brain Cogn 63:174-81. 2007..These results support the view that the successful episodic retrieval of newly learned faces is based on a dorsal visual stream mechanism...
Brain activation patterns during a selective attention test--a functional MRI study in healthy volunteers and unmedicated patients during an acute episode of schizophreniaElisabeth M Weiss
Department of General Psychiatry, Medical University Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
Psychiatry Res 154:31-40. 2007..Treatment with second generation antipsychotics may improve executive performance in patients with schizophrenia and facilitate a normalization of functional hypofrontality after symptomatic improvement...
Gender differences in regional cerebral activity during the perception of emotion: a functional MRI studyAlex Hofer
Medical University Innsbruck, Department of Biological Psychiatry, Anichstrasse 35, A 6020 Innsbruck, Austria
Neuroimage 32:854-62. 2006..Our findings suggest gender-related neural responses to emotional stimuli and could contribute to the understanding of mechanisms underlying gender-related vulnerability of the prevalence and severity of neuropsychiatric disorders...
Association between antipsychotic-induced elevation of liver enzymes and weight gain: a prospective studyMaria A Rettenbacher
Department of Biological Psychiatry, Medical University Innsbruck, Anichstrasse, Innsbruck, Austria
J Clin Psychopharmacol 26:500-3. 2006..We conclude that antipsychotic-induced elevation of liver enzymes is mostly transient and could be associated with weight gain...
Early changes of plasma lipids during treatment with atypical antipsychoticsMaria A Rettenbacher
Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
Int Clin Psychopharmacol 21:369-72. 2006..These results are important with regard to the increased risk for cardiovascular complications in patients with schizophrenia...
Olfactory functioning in patients with alcohol dependence: impairments in odor judgementsClaudia I Rupp
Medical University Innsbruck, Department of Psychiatry, Anichstrasse 35, 6020 Innsbruck, Austria
Alcohol Alcohol 39:514-9. 2004..However, olfactory functioning with regard to the immediate, perception driven odor associations is unknown. Therefore, this study assessed olfactory judgements in nonamnesic and nondemented patients with alcohol dependence...
Clock drawing, clock reading, clock setting, and judgment of clock faces in elderly people with dementia and depressionThomas Bodner
Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, Austria
J Am Geriatr Soc 52:1146-50. 2004..To assess patient performance on different clock tasks...
Attitudes of patients with schizophrenia toward placebo-controlled clinical trialsMartina Hummer
Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, Austria
J Clin Psychiatry 64:277-81. 2003..Although much is known about the opinions of professionals concerning this issue, so far nothing is known about the opinions of patients who are most affected by the realization of placebo-controlled clinical trials...
An FMRI study of episodic encoding and recognition of words in patients with schizophrenia in remissionAlex Hofer
Department of Biological Psychiatry and Radiology, Innsbruck University Clinics, Anichstrasse 35, A 6020 Innsbruck, Austria
Am J Psychiatry 160:911-8. 2003..Verbal memory deficits are among the most severe cognitive deficits observed in patients with schizophrenia. This study examined patterns of brain activity during episodic encoding and recognition of words in patients with schizophrenia...
Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivorsBernhard Holzner
Department of Biological Psychiatry, Innsbruck University Hospital, Innsbruck, Austria
Acta Oncol 43:153-60. 2004..Furthermore, unless patient data are compared with normative values, phenomena such as adaptation and response shift might be missed or misinterpreted...
Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medicationMaria A Rettenbacher
Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, Austria
Pharmacopsychiatry 37:103-9. 2004....
Olanzapine induces insulin resistance: results from a prospective studyChristoph F Ebenbichler
Department of Medicine, University of Innsbruck, Innsbruck, Austria
J Clin Psychiatry 64:1436-9. 2003..The aim of this study was to compare glucose metabolism in patients with schizophrenia receiving olanzapine with that in control subjects...
Brain activation patterns during a selective attention test-a functional MRI study in healthy volunteers and patients with schizophreniaElisabeth M Weiss
Department of Biological Psychiatry, Innsbruck University Clinics, Anichstrasse 35, A 6020 Innsbruck, Austria
Psychiatry Res 123:1-15. 2003....
No evidence for an association between serum cholesterol and the course of depression and suicidalityEberhard A Deisenhammer
Department of General Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A 6020, Innsbruck, Austria
Psychiatry Res 121:253-61. 2004..Cholesterol levels do not appear to be an appropriate biological marker for suicidality during the first 4 weeks of treatment in patients with a major depressive episode...
Neural correlates of episodic encoding and recognition of words in unmedicated patients during an acute episode of schizophrenia: a functional MRI studyAlex Hofer
Department of Biological Psychiatry, Innsbruck University Clinics, Austria
Am J Psychiatry 160:1802-8. 2003..The same procedure was used in this study to investigate unmedicated patients during an acute episode of schizophrenia...
Reduced olfactory sensitivity, discrimination, and identification in patients with alcohol dependenceClaudia I Rupp
University Clinics of Innsbruck, Department of General Psychiatry, Anichstrasse 35, 6020 Innsbruck, Austria
Alcohol Clin Exp Res 27:432-9. 2003..Various olfactory deficits have been reported in the alcohol-induced amnestic syndrome (Korsakoff's syndrome). Less is known about olfactory functioning in nonamnesic and nondemented alcoholic patients...
Fatigue in ovarian carcinoma patients: a neglected issue?Bernhard Holzner
Department of Biological Psychiatry, Innsbruck University Hospital, Innsbruck, Austria
Cancer 97:1564-72. 2003..The main focus of the current study was to assess fatigue in these patients and to investigate the impact of fatigue and other clinical and psychosocial variables on their quality of life (QOL)...
The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophreniaAlex Hofer
Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, Austria
Int J Neuropsychopharmacol 6:201-6. 2003..With regard to side-effects, we could not find any significant difference between groups. Altogether, response and side-effects to clozapine treatment do not seem to be determined by the chronicity of the disorder...
Olfactory functions and volumetric measures of orbitofrontal and limbic regions in schizophreniaClaudia I Rupp
Department of Psychiatry, Medical University Innsbruck, Austria
Schizophr Res 74:149-61. 2005..In this study, we examined the relationship between different olfactory functions and volumes of the hippocampus-amygdala complex (HAC) and the orbitofrontal brain region using magnetic resonance imaging (MRI)...
Executive function and memory in relation to olfactory deficits in alcohol-dependent patientsClaudia I Rupp
Department of Psychiatry, Innsbruck Medical University, Innsbruck, Austria
Alcohol Clin Exp Res 30:1355-62. 2006....
Osteoporosis in patients with schizophreniaMartina Hummer
Department of Biological Psychiatry, Innsbruck University Hospital, Austria
Am J Psychiatry 162:162-7. 2005..The authors' goals were to investigate the association between schizophrenia and a decrease in bone mineral density and to get more insight into potential underlying pathophysiological mechanisms...
[The role of alcohol and/or benzodiazepines in occupational accidents compared to accidents due to other causes]Ilsemarie Kurzthaler
Abteilung für Biologische Psychiatrie, Universitätsklinik für Psychiatrie, Innsbruck, Osterreich
Wien Med Wochenschr 154:482-8. 2004..76 +/- 0.58 g/l) compared to other injuries (1.63 g/l +/- 0.74 g/l). No correlations were found concerning benzodiazepine use and demographic variables and all measured benzodiazepine plasma levels were within the therapeutic range...
Alcohol and/or benzodiazepine use in injured road usersIlsemarie Kurzthaler
Innsbruck University Clinics, Department of Biological Psychiatry, Innsbruck, Austria
Hum Psychopharmacol 18:361-7. 2003..Concerning alcohol or benzodiazepine use, females showed lower frequencies of both alcohol and benzodiazepine positive blood samples. The frequency of alcohol use was higher in patients <or= 60 years of age...
The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophreniaElisabeth M Weiss
Department of Biological Psychiatry, Innsbruck University Clinics, Anichstrasse 35, 6020 Innsbruck University Clinics, Anichtrasse 35, 6020 Innsbruck, Austria
Psychopharmacology (Berl) 162:11-7. 2002..In this context it also addresses several methodological and conceptional issues that limited the comparison of these studies...
Brain activation patterns during a verbal fluency test-a functional MRI study in healthy volunteers and patients with schizophreniaElisabeth M Weiss
Department of Biological Psychiatry, Innsbruck University Clinics, Anichstrasse 35, 6020 Innsbruck, Austria
Schizophr Res 70:287-91. 2004..These data indicate that high-functioning schizophrenia patients show a reduced language lateralization of the frontal cortex compared to healthy controls...
Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effectsAlex Hofer
Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, Austria
J Clin Psychiatry 65:932-9. 2004..Factors deemed relevant in this context include severity of symptoms, antipsychotic-induced side effects, sociodemographic variables, and patients' subjective response to medication...
Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapineB Sperner-Unterweger
Innsbruck University Clinics, Department of Biological Psychiatry, Austria
Br J Psychiatry 172:82-4. 1998..Discontinuation of clozapine led to an acute psychotic relapse. During clozapine treatment the patient developed severe neutropenia...
Olanzapine-induced weight gain and disturbances of lipid and glucose metabolismUrsula eder-Ischia
Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, Austria
Essent Psychopharmacol 6:112-7. 2005..Clinicians should take these risks seriously in prescribing these antipsychotics and employ intelligent safeguards if and when they use them...
Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challengesW Wolfgang Fleischhacker
Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
J Clin Psychiatry 69:514-9. 2008....
AripiprazoleW Wolfgang Fleischhacker
Department of Biological Psychiatry, Medical University Innsbruck, Austria
Expert Opin Pharmacother 6:2091-101. 2005..Further studies in other indications and clinical trials that confirm results from the Phase II and III clinical development programme are eagerly awaited...
Differential diagnosis of depressed mood in patients with schizophrenia: a diagnostic algorithm based on a reviewA Hausmann
Department of General Psychiatry, Innsbruck University Hospital, Innsbruck, Austria
Acta Psychiatr Scand 106:83-96. 2002..To review the available literature on depressive symptomatology in schizophrenia in order to establish a diagnostic algorithm of depressive syndromes in schizophrenia...
Trends in the pharmacological treatment of patients with schizophrenia over a 12 year observation periodMonika Edlinger
Department of Biological Psychiatry, Medical University Innsbruck Anichstrasse 35 A 6020, Austria
Schizophr Res 77:25-34. 2005..All in all, the pharmacological management of schizophrenia patients is increasingly in tune with current treatment guidelines...
Antipsychotics in the early stage of developmentFalko Biedermann
Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Tyrol, Austria
Curr Opin Psychiatry 22:326-30. 2009....
Experimental antipsychotics and metabolic adverse effects--findings from clinical trialsAlexander Tschoner
Department of Internal Medicine I, Medical University Innsbruck, Center of Internal Medicine, 6020 Innsbruck, Austria
Curr Opin Investig Drugs 10:1041-8. 2009..This review discusses some of the most recently developed antipsychotic compounds that have undergone clinical assessment from the perspective of their metabolic impact...
Second-generation antipsychotic long-acting injections: systematic reviewW Wolfgang Fleischhacker
Medical University Innsbruck, Department of Psychiatry and Psychotherapy, Anichstrasse 35, A 6020 Innsbruck, Austria
Br J Psychiatry Suppl 52:S29-36. 2009..Second-generation antipsychotics (SGAs) represent an advance in the long-term management of schizophrenia...
Off-label use of antipsychotic drugsE Weiss
Department of Biological Psychiatry, University of Innsbruck, Austria
J Clin Psychopharmacol 20:695-8. 2000..In classical indications, clozapine was used more frequently (50%) than other antipsychotics. Melperone was primarily prescribed for off-label use...
Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cellsJ Engl
Clinical Department of Internal Medicine, Clinical Division of General Internal Medicine, Innsbruck, Austria
Mol Psychiatry 10:1089-96. 2005..We conclude that olanzapine impairs glycogen synthesis via inhibition of the classical insulin-signaling cascade and that this inhibitory effect may lead to the induction of insulin resistance in olanzapine-treated patients...
Sex differences in brain activation pattern during a visuospatial cognitive task: a functional magnetic resonance imaging study in healthy volunteersE Weiss
Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, Austria
Neurosci Lett 344:169-72. 2003..Our results point to gender specific differences in the neuropsychological processes involved in mental rotation tasks...
The impact of hemoglobin levels on fatigue and quality of life in cancer patientsB Holzner
Department of Biological Psychiatry, Innsbruck University Hospital, Austria
Ann Oncol 13:965-73. 2002..The objective of the present study was to investigate the relationship between hemoglobin (Hb) levels and the subjective experience of fatigue and quality of life in cancer patients with mild or no anemia undergoing chemotherapy...
Switching between second-generation antipsychotics: why and how?Monika Edlinger
Department of Biological Psychiatry, Innsbruck Medical University, Innsbruck, A 6020, Austria
CNS Drugs 19:27-42. 2005..We review the available evidence concerning techniques, problems and consequences when switching from one second-generation antipsychotic agent to another and discuss potential difficulties...
Tolerability of antipsychotics: recent controversies and future managementW Wolfgang Fleischhacker
Department of Biological Psychiatry, Medical University of Innsbruck, Austria
J Clin Psychiatry 70:e06. 2009....
Attitudes toward antipsychotics among outpatient clinic attendees with schizophreniaAlex Hofer
Department of Biologic Psychiatry, University Clinics Innsbruck, Austria
J Clin Psychiatry 63:49-53. 2002..CONCLUSION: Our results suggest that special attention should be paid to patients who experience positive symptoms or sedation and to those with relative absence of symptoms, who are therefore tempted to stop taking medication...
Improvement of cognitive dysfunction after treatment with second-generation antipsychoticsElisabeth Weiss
Arch Gen Psychiatry 59:572-3; author reply 573-5. 2002
The soluble leptin receptor in olanzapine-induced weight gain: results from a prospective studyChristoph Ebenbichler
Schizophr Res 75:143-6. 2005
Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patientAlex Hofer
J Clin Psychiatry 64:1267-8. 2003
Treatment of antipsychotic-associated hyperglycemia with pioglitazone: a case seriesMonika Edlinger
J Clin Psychopharmacol 27:403-4. 2007
Transient hyperproinsulinemia during treatment with clozapine and amisulprideMaria A Rettenbacher
J Clin Psychiatry 65:878-9. 2004
Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patientsAlexandra B Whitworth
Psychiatry Res 140:225-37. 2005..Our results do not support the hypothesis that schizophrenia leads to progressive volume reduction in these areas, although there may be a subset of patients with morphologically visible disease progression...
Attitudes towards medication in patients with schizophreniaAlex Hofer
Acta Psychiatr Scand 113:161-2. 2006
Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual useW Wolfgang Fleischhacker
Psychopharmacology (Berl) 169:207-10. 2003
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trialRene S Kahn
Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, Netherlands
Lancet 371:1085-97. 2008..We aimed to compare the effectiveness of second-generation antipsychotic drugs with that of a low dose of haloperidol, in first-episode schizophrenia...
Second generation antipsychoticsW Wolfgang Fleischhacker
Psychopharmacology (Berl) 162:90-1. 2002
